|
Harrow Health, Inc. (HROW) Valoración de DCF
US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Harrow Health, Inc. (HROW) Bundle
¡Descubra el verdadero potencial de Harrow Health, Inc. (HROW) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los cambios afectan la valoración de Harrow Health, todo dentro de una plantilla de Excel fácil de usar.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.2 | 48.9 | 72.5 | 88.6 | 130.2 | 167.0 | 214.2 | 274.7 | 352.3 | 451.8 |
| Revenue Growth, % | 0 | -4.48 | 48.3 | 22.24 | 46.95 | 28.25 | 28.25 | 28.25 | 28.25 | 28.25 |
| EBITDA | 1.4 | 3.5 | -10.1 | -3.2 | 9.7 | -.1 | -.1 | -.1 | -.1 | -.2 |
| EBITDA, % | 2.81 | 7.14 | -13.99 | -3.62 | 7.47 | -0.03727946 | -0.03727946 | -0.03727946 | -0.03727946 | -0.03727946 |
| Depreciation | 2.7 | 2.7 | 2.4 | 3.7 | 12.3 | 9.3 | 11.9 | 15.2 | 19.5 | 25.1 |
| Depreciation, % | 5.2 | 5.61 | 3.31 | 4.14 | 9.48 | 5.55 | 5.55 | 5.55 | 5.55 | 5.55 |
| EBIT | -1.2 | .7 | -12.5 | -6.9 | -2.6 | -9.3 | -12.0 | -15.3 | -19.7 | -25.2 |
| EBIT, % | -2.39 | 1.53 | -17.3 | -7.75 | -2.01 | -5.58 | -5.58 | -5.58 | -5.58 | -5.58 |
| Total Cash | 29.9 | 32.6 | 50.7 | 96.3 | 82.8 | 119.8 | 153.6 | 197.0 | 252.7 | 324.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.0 | 2.7 | 4.5 | 6.4 | 36.5 | 17.0 | 21.8 | 27.9 | 35.8 | 45.9 |
| Account Receivables, % | 3.93 | 5.45 | 6.23 | 7.21 | 28.03 | 10.17 | 10.17 | 10.17 | 10.17 | 10.17 |
| Inventories | 3.3 | 4.0 | 4.2 | 6.5 | 10.9 | 12.1 | 15.5 | 19.8 | 25.4 | 32.6 |
| Inventories, % | 6.45 | 8.11 | 5.82 | 7.38 | 8.35 | 7.22 | 7.22 | 7.22 | 7.22 | 7.22 |
| Accounts Payable | 7.4 | 3.6 | 5.2 | 6.4 | 21.4 | 17.6 | 22.6 | 29.0 | 37.2 | 47.7 |
| Accounts Payable, % | 14.48 | 7.46 | 7.14 | 7.27 | 16.46 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 |
| Capital Expenditure | -1.8 | -1.0 | -28.5 | -7.8 | -152.6 | -51.3 | -65.8 | -84.4 | -108.3 | -138.9 |
| Capital Expenditure, % | -3.59 | -2.03 | -39.34 | -8.77 | -117.17 | -30.75 | -30.75 | -30.75 | -30.75 | -30.75 |
| Tax Rate, % | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 | -1.96 |
| EBITAT | -25.4 | .7 | -12.6 | -6.9 | -2.7 | -9.3 | -12.0 | -15.3 | -19.7 | -25.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -22.5 | -2.6 | -39.3 | -13.9 | -162.3 | -36.9 | -69.1 | -88.7 | -113.7 | -145.9 |
| WACC, % | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -341.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -152 | |||||||||
| Terminal Value | -3,358 | |||||||||
| Present Terminal Value | -2,231 | |||||||||
| Enterprise Value | -2,572 | |||||||||
| Net Debt | 116 | |||||||||
| Equity Value | -2,689 | |||||||||
| Diluted Shares Outstanding, MM | 33 | |||||||||
| Equity Value Per Share | -82.44 |
What You Will Receive
- Comprehensive Financial Model: Harrow Health’s actual data facilitates accurate DCF valuation.
- Complete Forecast Customization: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate insights as you make adjustments.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- 🔍 Real-Life HROW Financials: Pre-filled historical and projected data for Harrow Health, Inc. (HROW).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Harrow Health’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Harrow Health’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Harrow Health, Inc. (HROW).
- Step 2: Review Harrow Health’s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and utilize the results for your investment decisions.
Why Choose This Calculator for Harrow Health, Inc. (HROW)?
- User-Friendly Interface: Crafted for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Valuation: Witness immediate updates to Harrow Health’s valuation as you modify inputs.
- Preloaded Data: Comes with Harrow Health’s actual financial metrics for swift evaluations.
- Preferred by Experts: Utilized by investors and analysts for informed decision-making.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing investments in Harrow Health, Inc. (HROW).
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare sectors.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Harrow Health, Inc. (HROW).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Health Industry Enthusiasts: Gain insights into how companies like Harrow Health, Inc. (HROW) are valued in the healthcare market.
What the Template Contains
- Historical Data: Includes Harrow Health, Inc.'s (HROW) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Harrow Health, Inc.'s (HROW) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Harrow Health, Inc.'s (HROW) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.